TENDER DOCUMENT (Not Transferable)

1

TENDER DOCUMENT

(Not Transferable)

Tender Ref.No. 128/GOMP/LAB/2014,

DIRECTOR MEDICAL SERVICES, (INCHARGE PROCUREMENT),

DIRECTORATE OF HEALTH SERVICES, GOVERNMENT OF MADHYA PRADESH

INVITES

“Tender for empanelment of Analytical laboratories

accredited by “National Accreditation Board for Testing and

Calibration” (NABL) for the analysis of samples of drugs for the

year 2014-15 for a period of 3 years”.

Director Medical Services (Incharge Procurement), Directorate of Health Services,

Government of Madhya Pradesh 4th Floor Satpura Bhawan Bhopal, Madhya Pradesh

Phone: 0755-2571694 Website: www.health.mp.gov.in

[For any further clarifications / queries on e-Tendering, e-Procurement Cell can be contacted at: Toll Free Nos.: 1800-274-5454, 1800-274-8484, Mobile No. 08965065346, 08965022417, Phone No. 0755-6500102 e-mail: [email protected] Helpdesk Address : TCS helpdesk, 5th Floor , Corporate Zone, DB Mall , Arera Hills , Bhopal]

2

NOTICE INVITING TENDERS (NIT)

DIRECTOR MEDICAL SERVICES (INCHARGE PROCUREMENT),

DIRECTORATE OF HEALTH SERVICES, , GOVERNMENT OF MADHYA PRADESH AT

4Th Floor SATPURA BHAWAN BHOPAL-462004 URL: www.health.mp.gov.in

PHONE: 0755-2571694

Tender Enquiry No.: 128/GOMP/Drug Testing/2014 Dated: 6.02.2014

NOTICE INVITING TENDERS (NIT)

(1) Director Medical Services, In charge Procurement, Directorate of Health Services, Government of Madhya Pradesh, for and on behalf of Governor of Madhya Pradesh invites Online Tenders, from eligible and qualified bidders for “Empanelment of Analytical laboratories accredited by “National Accreditation Board for Testing and Calibration” (NABL) for the analysis of samples of drugs for a period of 3 years”.

(2) The Schedule of E-Tendering Activities are as under:

Sr. No. Activity Date and Time

1 Start of Purchase of Tender Document 07/02/2014 at 18:00 Hrs

2 End of Purchase of Tender Document 03/03/2014 at 18:00 Hrs

3 Date of Pre-Bid Meeting 20/02/2014 at 12:00 Hrs

4 End of Bid Submission 04/03/2014 at 11:30 Hrs

5 Opening of Technical Bid (Envelope-A) 04/03/2014 at 12:30 Hrs.

6 Opening of Financial Bid (Envelope-C) 18/03/2014 at 12:30 Hrs

(3) Tender Documents may be viewed or purchased online by interested and eligible bidders from the website www.mpeproc.gov.in on the above mentioned dates after online payment of Tender fee of Rs.1,000 and processing fee of Rs. 281. Tender document may also be viewed from the website www.health.mp.gov.in.

(4) The Pre-bid meeting shall be held on the date and time given above to provide clarifications to prospective bidders regarding terms and conditions given in Tender Document. The value of pre-bid meeting shall be 4th Floor, Meeting Hall at the address below.

(5) Bidders can submit its tender online at www.mpeproc.gov.in on or before the ‘End of Bid Submission’ date and time given above. The Physical copy of the Technical Bid only should also be submitted at the address below latest by 11:30 hrs on 04/03/2014.

(6) All further notifications/amendments, if any shall be posted on www.mpeproc.gov.in and www.health.mp.gov.in only. No separate communication shall be made with individual Bidders

Director-Medical Services (Incharge Procurement)

Directorate of Health Services, 4th Floor, SatpudaBhavan

Bhopal- 462004

3

ONLINE Tender for empanelment of Analytical laboratories accredited by “National Accreditation Board for Testing and Calibration” (NABL) for the

analysis of samples of drugs ,Surgicals and Suture items for a period of 3 years”.

The Director Medical Service, (In-charge, Procurement) , Government of Madhya Pradesh (GOMP), (hereinafter referred as Tender Inviting Authority and

also called the Tender Acceptance Authority unless the context otherwise requires) invites online TENDER FOR EMPANELMENT OF ANALYTICAL LABORATORIES ACCREDITED BY “NATIONAL ACCREDITATION BOARD FOR TESTING AND CALIBRATION” (NABL) FOR THE ANALYSIS OF SAMPLES OF DRUGS FOR A PERIOD OF 3 YEARS”.

1. LAST DATE FOR ONLINE RECEIPT OF TENDERS.

(a) The last date for online receipt of tenders shall be as per “Schedule of E-

Tendering Activities” given above. (b) The bid will be valid for a period of 180 days from the date of opening of

Cover A (Technical Bid). Prior to expiration of the bid validity the Tender Inviting Authority may request the bidders to extend the bid validity for further period as deemed fit.

2. Qualification Criteria / Requirements:

a) The Analytical Testing Laboratory should be accredited by “National

Accreditation Board of Laboratories” (NABL) and such accreditation should be

valid on the date of submission of Tender. Tenderer should submit copy

certificate of Accreditation issued by NABL (duly certified by a Chartered

Accountant) for Chemical/ Biological testing including testing of drugs and

medical supplies as the case may be.

b) The Analytical Testing Laboratory should have approval under the Drugs and

Cosmetics Act, 1940 (including its amendments) and should comply with

Schedule L-1 of Drugs and Cosmetic Act. A valid document issued from regulatory

authority in support of this should be provided.

c) The Analytical Testing Laboratory should have at least 5 (five) years experience in

the analysis of drugs (biological and/or non-biological). The bidder should

provide details of past experience in the proforma given in Annexure - I.

d) The Analytical Laboratory should have achieved an average annual turnover of at

least Rs.25 Lakhs during last three years i.e. 2010-11, 2011-12 and 2012-13. The

Government Laboratories, Research & Development Laboratories, Laboratories

run by Co-operative body & Educational Institutions are exempted from the

turnover criteria

e) Analytical Laboratory, which has manufacturing activity, shall not be eligible to

participate in the tender. Agents of Analytical Testing Laboratories are not

eligible to participate in the tender.

4

f) All those bidders shall be disqualified for all quoted products if any person (s) (i.e

partner (s) in case of a partnership firm, member (s) in case of a company or the

proprietor in case of a proprietorship firm, as the case may be) holds 20% or

more share (ownerships) in more than one bidding entities who have quoted for

same product (s).

3. Instructions to Tenderers.

A. GENERAL CONDITIONS.

Tender documents can be purchased only online from www.mpeproc.gov.in by making

online payment. The tender document can also be downloaded from the website

http://health.mp.gov.in for purpose of viewing only and it shall not be entertained as VALID

download of tender document. To participate in tender bidder should complete stages of

PURCHASE, DOWNLOAD & FINAL BID SUBMISSION through www.mpeproc.gov.in. Bid

Submitted only on-line will be accepted. No objections related to technical evaluation

would be accepted after the price bid opening.

(i) Tender documents may be purchased only Online from www.mpeproc.gov.in

on mentioned dates as in the ‘Schedule of E-Tendering Activities’ given above.

Tender inviting Authority will not be responsible in any way for any delay.

(ii) All tenders must be accompanied with Earnest Money Deposit as specified in

clause 4.1(a) of the Tender document. Scan copy of the earnest money

instrument should be uploaded online.

(iii) Tenders will be opened online in the presence of bidders / authorized

representatives who chooses to attend on the specified date and time given in

‘Schedule of E-Tendering Activities’ at Meeting Hall ,4th

Floor, Satpura Bhawan

,Bhopal -462 004.

(iv) (a) At any time prior to the date of submission of Tender, Tender Inviting

Authority may, for any reason, whether on his own initiative or in response to a

clarification requested by a prospective Bidder, modify the condition in Tender

documents by an amendment. All the prospective bidders who have received

the tender document will be notified of the amendment only through website,

i.e. www.mpeproc.gov.in and that will be binding on them. In order to provide

reasonable time to take the amendment into account in preparing their bid,

Tender Inviting Authority may at his discretion, extend the date and time for

submission of tenders.

(b) Any person who has purchased/downloaded the tender document

should watch for amendment, if any, on the website of

GOMP/www.mpeproc.gov.in and Tender Inviting Authority will not issue

separate communication to them.

Interested eligible bidders may obtain further information in this regard from

the office of the Tender Inviting Authority or in person on the day of pre bid

meeting.

5

B. Earnest Money Deposit (EMD)

(i) All tenders must be accompanied with EMD of Rs. 5000/- in the form of

unconditional irrevocable Bank Guarantee issued from a scheduled bank

or Demand Draft or Fixed Deposit Receipt (FDR) and should be in the

name of “Director Medical Services (Incharge Procurement), Directorate

of Health Services, Madhya Pradesh which will also be uploaded online

www.mpeproc.gov.in . (ii) In case of EMD in form of Bank Guarantee (BG), the BG should be valid

for 180 days from the date of technical bid opening.

(iii) No exemption from submission of EMD is permitted and the bids found

without EMD as above will be summarily rejected.

(iv) Bids submitted with short validity of EMD may be rejected.

(v) Bid Security may be forfeited.

(a) If a Bidder withdraws its bid during the period of bid validity ; or

(b) In case of successful Bidder, if the Bidder fails;

(i) To sign the Contract / Agreement in accordance with clause

3.K; or

(ii) To furnish performance security in accordance with clause 3.L

(c) If the Bidder does not accept the corrected amount of Price Bid,

as the case may be, the Bid will be rejected, and the Bid security

may be forfeited.

C. Pre-bid meeting, Clarifications and Amendments:

(i) Interested eligible tenderers may obtain further information from the

office of the Tender Inviting Authority or in person on the day of pre bid

meeting. After pre-bid meeting, the prospective bidders can seek

clarification within next two days either through e-mail or through

written request. No clarification shall be provided subsequently.

(ii) At any time prior to the date of submission of Tender, Tender Inviting

Authority may, for any reason, whether on his own initiative or in

response to a clarification requested by a prospective Tenderer, modify

any condition in Tender documents by an amendment. All the

prospective tenderers who have received the tender document will only

be notified of the amendment through publication on the website, i.e.

http://health.mp.gov.in and www.mpeproc.gov.in that will be binding on

all the Tenderers. In order to provide reasonable time to take the

amendment into account in preparing their bid, Tender Inviting

Authority may at his discretion, extend the date and time for submission

of tenders.

(iii) Any Tenderer who has purchased the tender document should watch

for amendment, if any, on the website given at para 3. C(ii) above.

Tender Inviting Authority will not issue separate communication to the

bidders in this regard.

6

D. Preparation of Bid: The bids should be prepared in ‘Two Covers’ i.e. “Technical Bid

(Cover-A) – ‘Online’ and ‘Physical’ and “Price Bid (Cover-C) – Online”. The following

instructions should be followed:

TECHNICAL BID - COVER “A”

The Tenderer should submit the Technical Bid online as well as physical copy. All pages

of the Technical Bid should be signed and sealed by the Tenderer. All documents

submitted as part of the Technical Bid, which are photocopy should be attested by the

Tenderer and also be notarized on each page.

The tenderer shall submit a checklist of documents enclosed with page in the

enclosed proforma in Annexure VIII.

The following shall constitute Technical Bid:

a) The EMD (in original) as mentioned in para 3. B should submit manually as part of

Technical Bid.

b) Documentary evidence for the constitution of the company /Firm such as

Memorandum and Articles of Association, Partnership deed etc. with details of the

Name, Address, Telephone Number, Fax Number, e-mail address of the firm and of the

Managing Director / Partners / Proprietor.

c) The list of present Directors in the board of the Company duly certified by a Company

Secretary of a Company/Practicing Company Secretary/Chartered Accountant to be

furnished.

d) Bidders should submit copy of Certificate of Accreditation issued by NABL (duly

certified by a Chartered Accountant) for Chemical/ Biological testing including testing

of drugs and pharmaceuticals as well as mechanical testing (as the case may be).

e) The tenderer should furnish self attested and notarized photocopy of Analytical

License under Rule 150(B) duly renewed up to date, issued by the Drugs Controller

for testing and licensed in biological, non-biological drugs duly attested by Chartered

Accountant.

f) The instruments such as power of attorney / resolution of board etc., authorizing an

officer of the tenderer to sign the bid on behalf of Tenderer should be enclosed with

the tender.

g) Authorization letter nominating a responsible person of the tenderer to transact the

business with the Tender Inviting Authority

h) The Laboratory should be operating under Quality Assurance Programme and in

support; the bidder shall provide Quality Manual, Quality Policy and Master List of

Standard Operating Procedures along with name of Quality Assurance Manager

indicating his qualification and experience.

i) The Tenderer should submit an undertaking that they will retain residual sample for

six months after submission of report and agree to undertake analysis in the

presence of the representative(s) of Directorate of Health Services Madhya Pradesh

in case of doubt or otherwise.

j) Self attested and notarized copy of certificate of registration for service tax should

be enclosed Annexure - II.

7

k) Self attested and notarized documents of the following should be furnished in the

formats given in Annexure III.

a. The list of qualified personnel employed in the laboratory.

b. The list of sophisticated instruments available in the laboratory.

c. Micro Biological facilities available in the laboratory.

l) A declaration in the proforma given in Annexure IV duly signed and notarized.

m) Details of Laboratory in Annexure – V.

n) Non Conviction Certificate for the last three years, i.e., 2010-2011, 2011-12 and

2012-2013 issued by the competent authority.

o) Annual turnover statement certified by the auditors for last three years i.e., 2010-

2011, 2011-12 and 2012-2013. Balance Sheet and Profit and Loss Account duly

certified by the Auditors for the last three years i.e., i.e., 2010-2011, 2011-2012 and

2012-2013.

p) Documentary evidence, if any, for having undertaken testing of products for exports.

q) A declaration that the bidder has not been blacklisted by any State / Central

Government Organization.

r) The list of Drugs (along with Item Code) quoted for analysis should be given in

Annexure VI. Please note that this list should not mention testing charges.

s) The specifications of drugs for testing are tentative they can be changed before the

samples are being sent for testing.

Price Bid(Envelope code ‘C’):

a) The Price Bid has to be submitted online with “Cover C” Price Bid in excel format. b) The Bidder should submit Price Bid by giving the rate of Testing Charges for the

complete analysis of “single sample” of an item and not for individual test to be

performed on the sample.

c) The rates quoted should be inclusive of all taxes but exclusive of service tax. The

Service tax as per prevailing rate shall be paid to the Laboratory upon submission of

claim and proof of Service Tax Registration

d) The rates quoted and accepted will be binding on the tenderer for the stipulated

period and on no account any revision will be entertained till the completion of the

contract period.

E. Taxes and Duties:

(i) The Service tax as per prevailing rate shall be paid to the Laboratory upon

submission of claim and proof of Service Tax Registration.

(ii) Further the tenderers are requested to note that any taxes to be deducted

at source at the rate fixed by the appropriate Govt. in i.e. State / Central,

shall be deducted at the time of payment against the services.

F. Submission of Bids:

(i) The bid submission date/time shall be as per Table given under “Schedule of

E-Tendering Activities”.

8

(ii) The bid submission date/time could be amended at the discretion of Tender

Inviting Authority in case of technical problems. Tender inviting Authority will

not be responsible in any way for any delay.

(iii) The Physical Copy of the Technical Bid documents must also be submitted in a

sealed cover and superscribed as “Tender for empanelment of Analytical

laboratories for the analysis of samples of drugs for a period of 3 years”.

(iv) The Physical Copy of the Technical Bid should reach the Director Incharge

Procurement at the Directorate of Health Services , 4th

floor Satpura

Bhawan,Bhopal 462 004 on or before the time and date given in “Schedule

of E-Tendering Activities.

G. Modification and Withdrawal of Bids

(i) The Bidder may modify or withdraw its bid prior to bid opening,

provided that written notice of the modification or with drawl is

received by the Tender Inviting Authority prior the deadline

prescribed for submission of bids.

(ii) No bid can be modified subsequent to the deadline for submission of

bids. No bid can be withdrawn in the interval between the deadline

for submission of bids and expiration of period of bid validity specified

by the bidder on the bid form. With drawl of bid during this interval

may result in the Bidders forfeiture of its bid security.

H. Tender Opening:

(i) Tenders will be opened in the presence of tenderers / authorized

representatives who choose to attend as per date/time specified in the

Table given under “Key Dates” above at “Meeting Hall, 4th

Floor,

Satpura Bhawan, Bhopal, Madhya Pradesh. Only one person carrying

authorization letter from the bidder will be allowed to attend the bid

opening.

(ii) If the office happens to be closed on the key dates specified above, such

events shall happen on the next working day at the same time and

venue.

(iii) The Cover “A” will be opened first, and after scrutiny and

confirmation of the documents and the information furnished therein,

including inspection of the laboratory, if required, eligible and

qualified laboratories will be shortlisted and will be commutated

through health web site or email.

(iv) The price bid of technically qualified bidders shall be opened on the

date/time specified in the Table given under “Key Dates /

Information”.

(v) The acceptable rates for analysis will be decided and communicated

on website http://health.mp.gov.in and by email. I. Validity of Bids

The bids will be valid for a period of 180 days from the date of opening of Cover “A”

(Technical Bid). In exceptional circumstances, the Tender Inviting Authority may

solicit the Bidder’s consent for an extension of the period of validity. The request and

response thereto should be made in writing (or by e-mail), the bid security provided

9

shall be suitably extended. Bidder may refuse the request without forfeiture of its

bid security

J. Acceptance of Tender

a) Acceptance of tender will be communicated based on the lowest rates quoted by

different firms and subject to the approval of competent authority,

b) The Tender inviting authority, reserves the right to accept or reject any tender for

any one or more of the items tendered for, without assigning any reason.

c) Number of laboratories to be empanelled shall be decided, at the time of finalization

of tender, based on work load of Tender Inviting Authority. No

appeal/representation from the bidder (s) shall be accepted on number of

laboratories to be empanelled by the Tender Inviting Authority.

d) All The L-2 and L-3 bidders will be invited to match the rate quoted by the L1 Bidder.

In case, L-2 and L-3 agree so, they shall also be empanelled.

e) The Tender inviting authority will reject the tenders of blacklisted Laboratories and

reserve the right to reject those whose past performance with TNMSC/GoMP was

poor.

K. Agreement

a) All tenderers who are empanelled will have to execute an agreement in a non-

judicial stamp-paper of value Rs.100/- (Stamp duty to be paid by the tenderer), in

favour of Director Medical Services (Incharge Procurement), Directorate of Health

Services, Madhya Pradesh.

b) Tenderer has to execute the agreement within 15 days from the date of receipt of

the intimation by tender inviting authority informing that their tenders have been

accepted. The format of agreement will be as per Annexure IX

c) If the successful tenderer fails to execute the agreement and payment of security

deposit within the time specified or withdraws the tender after intimation of the

acceptance of the tender has been sent or owing to any other reasons, the tenderer

is unable to undertake the contract, the empanelment will be cancelled and the

Earnest Money Deposit of the tenderer shall stand forfeited. Such tenderer(s) will

also be liable for all damages sustained by the Tender Inviting Authority / Ordering

Authority by reasons of breach of tender conditions. Such damages shall be

assessed by the Tender Inviting Authority, Directorate of Health Services, and

Government of Madhya Pradesh whose decision shall be final.

L. Performance Security Deposit

The successful tenderers shall be required to pay a performance security deposit of

Rs.50,000/- at the time of execution of the agreement reference in clause 3.B.(iv) (ii)

above in the form of Unconditional Irrevocable Bank Guarantee issued by a

Scheduled Bank (Pledged to DIRECTOR MEDICAL SERVICES, (INCHARGE

PROCUREMENT), Directorate of Health Services, Madhya Pradesh payable at Bhopal.

M. Payment Provisions

(i) No advance payment towards any analysis will be made to the empanelled tenderer.

(ii) No payment will be made for the incomplete analysis or incomplete report.

10

(iii)Payments towards the analysis of Drugs will be made, strictly as per rules of the

Directorate of Health Services, Government of Madhya Pradesh.

(iv) Payment will be made centrally by the Tender inviting authority.

(v) The payment shall be released within 45 days of receipt of claim from Laboratory

upon submission of Test reports of the samples tested and soft copy of related

chromatograms.

N. Description of Services and Performance Requirements:

a. The analysis will be carried out as per Pharmacopoeial monographs with the use of

Pharmacopoeial Reference Standards. In case of non pharmacopoeial methods the

laboratory can use methods that are validated as per ICH guidelines. The validation

protocols and Master list of Reference Standards shall be available for examination

of the representatives of Directorate of Health Services Madhya Pradesh.

b. The analysis will be carried out on the calibrated equipment and the laboratory will

provide the Master list of calibration for the examination to the representatives of

Directorate of Health Services Madhya Pradesh/Food and Drug Administration.

c. On empanelment and entrustment of the job, the Analytical Laboratory should

furnish the test reports within.

i) 10 days of receipt of the sample in case of Tablets, Capsules, Pessaries,

Ointments, Powder and Liquid Oral Preparations.

ii) 25 days of receipt of the sample in the case of I.V. Fluids, Injections, eye/ear

drops Disinfectants and those items requiring sterility testing.

iii) For any delay more than stipulated in 3.N.c.(i) & c.(ii) as the case

may be, 1% of the testing charges per week and the part there of would be

deducted as penalty. If consecutively for 4 times or more than 8 times in a year,

stipulated in 21 a(i)/a(ii) then the penalty for subsequent delays would be 2% of

testing charges per week and part thereof.

d) The laboratory should report on packaging and general description of the product.

All the tests mentioned in IP/BP/USP/Drugs & Cosmetics Act/BIS/ISO. Etc., (as the

case may be) should be carried out for each and every sample. The results obtained

in the test should be mentioned in figure (wherever possible). In case of a non-

pharmacopoeial drug, the laboratory should follow standards and validated

protocols as per ICH guidelines including stability indicating assays and provide the

details with the report. In all those cases where sustained release or delayed release

profiles are claimed, dissolution should invariably be performed.

e) “COMPLIES” or “PASS” in the result column of the report is treated as incomplete

report, if the result has some value. Every test report must have specific remarks

(i.e.) Standard Quality or Not of Standard Quality.

f) All test reports should be mailed to the ordering Authority and report should also be

uploaded on the website of SDMIS (State Drug Management Information System)

and simultaneously be E-Mailed to head office on

[email protected].

g) The Analytical Laboratory used for analysis of sample of a particular batch for pre-

delivery testing, either at the request of supplier or ordering authority, shall not be

11

given work for analysis of the same item with same batch during post-delivery

testing.

h) In case of failure of a sample, the result should be communicated immediately to the

Ordering Authority and to the head office or the manufacturer as the case may be

through phone / E-mail and the report should be sent with protocols.

i) If in any circumstances (like break down of instrument, non availability of reference

standard etc.) The Analytical Laboratory is unable to undertake analysis for a

sample, the same should be reported within 24 hours of receipt of such a sample by

E-mail and the sample should be returned to the concerned Ordering Authority of

the District.

j) If any sample is received in a damaged condition by the laboratory, the sample

should not be analyzed and the information should be sent immediately to the the

concerned Ordering Authority of the District by FAX or E-mail with a copy to head

office.

k) The Director Medical Services, (Incarge Procurement) or his authorized

representative(s) has / have the right to inspect the laboratories of the tenderers

who have submitted tenders, before taking any decision regarding empanelment.

Similarly, the Director Medical Services, (Incharge Procurement) ,Directorate of

Health Services, Madhya Pradesh or his authorized representatives may also inspect

any laboratory empanelled, at any point of time during the continuance of the

tender and terminate / cancel its empanelment or any orders issued to the

laboratory or not to entrust any further testing job to the laboratory based on facts

brought out during such inspections.

l) Non performance of any tender or empanelment conditions will disqualify a

laboratory to participate in the tender for the next five years.

m) To assess the correctness of the test results being given by the Empanelled

laboratories, at random, the Tender inviting Authority can exercise the option of

witness testing by its authorized representatives from the residual sample or

alternatively the residual samples may be sent to the Government Analyst for

testing and if any variation is found the result would be informed to empanelled

laboratories. If there is any variation in the test data more than 5% in the analytical

reports furnished by the empanelled laboratories (either pass or fail) with the

Government Lab for 3 times in assay test and 4 times for other than assay, in a year,

the empanelled laboratory will be blacklisted for a period of 5 years after following

the due process.

n) If it is revealed that the analytical Laboratory is involved in any form of fraud and

collusion with the suppliers of Directorate of Health Services, MP, the Analytical

Laboratory will be black listed for a period of 5 years. The tenderers shall also be

liable for action under criminal law and the matter will be notified to the concerned

Director of Drugs Control for penal action against them.

o) The Tender Inviting Authority, Directorate of Health Services, MP will be at liberty to

terminate empanelment without assigning any reasons. The tenderer will not be

entitled for any compensation whatsoever in respect of such termination.

p) In all matters pertaining to the tender, the decision of The Tender Inviting Authority

Directorate of Health Services, MP shall be final and binding.

q) In the event of any dispute arising out of the tender such dispute would be subject to

the jurisdiction of the civil courts within the Madhya Pradesh.

12

ANNEXURE-I Ref. Clause No: 2 c)

PROFORMA FOR PERFORMANCE STATEMENT (for a period of last 5 years)

Name of the Laboratory : ____________________________________ Address : ____________________________________

____________________________________

Types of Samples Analyzed No. of Samples Analyzed during ___________________________

2008-09, 2009-10, 2010-11, 2011-12, and 2012-13

01. Tablets / Capsules / Pessaries 02. Injectable 03. Liquid Orals 04. Ointments / Creams / Gels 05. Others (Drugs)

Signature : Date : Name of the Lab : Office Seal :

13

ANNEXURE – II Ref. Clause No: 3.D. j)

CERTIFICATE OF REGISTRATION FOR SERVICE TAX SHOULD BE ENCLOSED

14

ANNEXURE – III (A)

Ref. Clause No: 3.D. k) a.

LIST OF QUALIFIED PERSONNEL EMPLOYED IN THE IN THE LABORATORY

Name of the Staff Designation Qualification Experience (relevant to

analysis of drugs

Please indicate the Chemists approved by the regulatory authority for Biologicals and Non-biologicals


15

ANNEXURE – III (B) Ref. Clause No: 3.D. k) b.

LIST OF SOPHISTICATED INSTRUMENTS AVAILABLE IN THE LABORATORY

Sr. No. Name of the Equipment/ Instruments/ Apparatus

Date of Installation

Latest date of calibration

Status (Working / non-working

1

2

3

.

.

.

.

.

n

Please provide Calibration Schedules of the equipment along with an undertaking that the analysis will be carried out on calibrated equipment and the fact can be checked by the authorized representative(s) of the Tender Inviting Authority

Signature : Name of the Lab : Date :

16

ANNEXURE – III(C) Ref. Clause No: 3.D. k) c.

IN THE MICRO BIOLOGICAL FACILITIES SECTION

I. LIST OF STOCK CULTURES AVAILABLE II. EQUIPMENT AND CONSUMABLES FOR CARRYING OUT BET

TEST III. LIST OF EQUIPMENT/APPARATUS AVAILABLE WITHDATE

OF INSTALLATION IV. CALIBRATION SCHEDULE OF AUTOCLAVES, INCUBATORS,

OVENS, LAMINAR BENCH V. CLEAN ROOM PROTOCOLS OF STERILITY ROOM

Signature : Name of the lab : Date :

17

ANNEXURE IV Ref. Clause No: 3.D. l)

DECLARATION FORM

I / We _______________________________(Name of the tenderer)

having our office at ______________________________________________ Lab at -----------------------------------------------------------------------------------------------do declare that I/We have carefully read all the conditions of tender of Directorate of Health Services., Bhopal, for the tenders floated for empanelment of analytical testing laboratories for the analysis of drugs for the tender period of Three years from the date of acceptance and abide by all conditions set forth therein. I / We further declare that I / We posses valid License bearing No._______________________ valid up to.


ATTESTED BY NOTARY PUBLIC

18

ANNEXURE – V

Ref.Clause No: 3. D. m)

DETAILS OF LABORATORY Name of the Laboratory & Full Address : Name and contact number of Contact person: (Please give business landline and mobile no.) Phone No : Fax : E-mail : Branches & their Addresses : Date of Inception : Approval No. & Date : Issued by : Valid up to : Details of manufacturing activity if any : Name of the authorized signatory : (With proof of authority) Specimen Signature of the authorized Signatory : Specimen Signature of the officer who is authorized to sign the test reports along With designation :

19

Annexure-VI

Ref.Clause No: 3. D. r)

List of Drugs (along with Item Code) quoted for analysis

S.No. Drug

Code

Name Of Drug

Unit

Items Quoted for

Analysis (Please

use √)

1 MP0001 Acarbose Tablets I.P.50mg 10 x 10 Tab

2 MP0002 Aceclofenac Tablets I.P.100mg 10 x 10 Tab

3 MP0003 Acenocoumarol Tablets I.P 2 Mg 10x10 Tab

4 MP0004 Acenocoumarol Tablets I.P 4 Mg 10x10 Tab

5 MP0005 Acetazolamide Tablets I.P. 250mg 10 x 10 Tab

6 MP0006 Acyclovir Tablets I.P. - 200mg 10 x 10 Tab.

7 MP0007 Acyclovir Tablets I.P.- 800mg 10 x 10 Tab.

8 MP0008 Albendazole Tablet I.P. 400 mg (For ARSH program) 10 x 10 Tab.

9 MP0009 Allopurinol Tablets I.P.100 mg 10 x 10 Tab

10 MP0010 Allopurinol Tablets I.P.300 mg 10 x 10 Tab

11 MP0011 Alprazolam Tablets I.P. 0.25mg 10 x 10 Tab.

12 MP0012 Amiodarone Tablets I.P.100 mg 10x10 Tab

13 MP0013 Amiodarone Tablets I.P.200mg 10x10 Tab

14 MP0014 Amitriptyline Tab. IP - 25 mg 10 x 10 Tab.

15 MP0016 Amlodipine Tablets I.P. - 5mg 10 x 10 Tab.

16 MP0017 Amoxycillin and Clavulanic Acid Tab I.P.(500+125 mg) 10 x 10 Tab.

17 MP0018 Amoxycillin Capsules I.P. - 250 mg. 10 x 10 Cap.

18 MP0019 Amoxycillin Capsules I.P. - 500mg 10 x 10 Cap.

19 MP0021

Antacid ChewableTablet containing Aluminium

hydroxide equivalent to dried gel 200mg+ Magnesium

hydroxide 200mg+Simethicone 25 mg USP

10 x 10 Tab

20 MP0022 Artemether+Lumefantrine (20mg+120mg) Tab 1 x 6 Tab

21 MP0023

Artesunate 100 mg (3 Tab) +Sulphadoxine 750 mg -

Pyrimethamine 37.5 mg tab IP (1 tabs) (Labelling of

age group,Warning etc. should be done as per GOI

guidelines)

Antimalarial

Combi Blister

Pack

22 MP0024

Artesunate Tablets 25 mg (3 tab)+Sulphadoxine 125

mg -Pyrimethamine 6.25 mg Tablets IP(1 tabs)

(Labelling of age group,Warning etc. should be done as

per GOI guidelines)

Antimalarial

Combi Blister

Pack

23 MP0025

Artesunate Tablets 50 mg (3 Tab) +Sulphadoxine 500

mg -Pyrimethamine 25 mg Tablets IP (1 tabs)

(Labelling of age group,Warning etc. should be done as

per GOI guidelines)

Antimalarial

Combi Blister

Pack

24 MP0026

Artesunate Tablets 150 mg (3 Tab) +Sulphadoxine (500

mg+500 mg) -Pyrimethamine 25 mg +25 mg tab IP (2

tab) (Labelling of age group,Warning etc. should be

Antimalarial

Combi Blister

Pack

20

done as per GOI guidelines)

25 MP0027

Artesunate Tablets 200 mg Tab (3 tab)+Sulphadoxine

(750mg +750 mg) mg -Pyrimethamine 37.5 mg+37.5 mg

tab IP (2 tab) (Labelling of age group,Warning etc.

should be done as per GOI guidelines)

Antimalarial

Combi Blister

Pack

26 MP0029 Aspirin 150+Clopidogrel 75mg Tab 10 x 10 Tab

27 MP0030 Aspirin Tablets I.P. - 150mg 10 x 10 Tab

28 MP0031 Aspirin Tablets I.P. - 75 mg 10 x 10 Tab.

29 MP0032 Atenolol Tablets I.P.- 100mg 10 x 14 Tab

30 MP0032 Atenolol Tab. - 100mg - 10 X 14

31 MP0033 Atorvastatin Tablets I.P. - 20 mg 10 x 10 Tab

32 MP0034 Atorvastatin Tablets I.P.- 10 mg 10 x 10 Tab

33 MP0036 Azithromycin Tablets I.P. - 500mg 10 x 10 Tab.

34 MP0037 Azithromycin Tablets I.P.- 250mg 10 x 10 Tab.

35 MP0038 Betahistine Tablets I.P. 16 mg 10 x 10 Tab

36 MP0039 Betahistine Tablets I.P. 8 mg 10 x 10 Tab

37 MP0040 Biperiden Tablets I.P. 2mg (as hydrochloride) 10 x 10 Tab

38 MP0041 Bisacodyl suppositories I.P. - 5mg 10 x 10

39 MP0042 Bisacodyl Tablets I.P. - 5mg 10 x 10 Tab

40 MP0043

Calcium with vitamin D tablets USP Calcium carbonate

650mg eq. to elemental calcium 250mg and

Cholecalciferol USP 125 IU

10x10 Tab

41 MP0044

Calcium with vitamin D tablets USP Calcium carbonate

1.5g eq. to elemental calcium 600mg and

Cholecalciferol USP 400 IU

10 x 10 Tab

42 MP0045 Carbamazepine Tablets I.P - 200 mg 10 x 10 Tab

43 MP0046 Carbimazole Tablets I.P 20mg 10 x 10 Tab

44 MP0048 Carvedilol Tablets I.P. 3.125mg 10 x 10 Tab

45 MP0049 Carvedilol Tablets I.P. 6.25mg 10 x 10 Tab

46 MP0053 Cetirizine Tablets I.P. - 10 mg 10 x 10 Tab.

47 MP0054 Chloramphenicol capsules I.P.500 mg 10 x 10 Cap

48 MP0055 Chlordiazepoxide Tablets I.P. 25 mg 10 x 10 Tab

49 MP0056

Chlorine based compound (Sodium dicholoroiso

cyanurate)NADCC tablets 75 mg with available chlorine

45 mg) BIS

Pack 0f 1000 tab

50 MP0057 Chloroquine phosphate Tablets I.P. - 250mg 10 x 10 Tab.

51 MP0058 Chlorpheniramine Tablets I.P. - 4mg 10 x 10 Tab.

52 MP0063 Clomiphene Citrate Tablets I.P.25 mg 10 x 10 Tab

53 MP0066 Clonidine Tablets I.P. 100mcg 10x10 Tab

54 MP0068 Clotrimazole Vaginal Tablet I.P. - 100mg 1 x 6 Tab.

55 MP0069 Codeine Tablets I.P.10mg Tab 10 x 10 Tab

56 MP0070 Dicyclomine Tablets I.P. - 20mg 10 x 10 Tab.

57 MP0071 Diethylcarbamazine Tablets I.P. - 100mg 10 x 10 Tab.

58 MP0072 Diethylcarbamazine Tablets I.P. - 50 mg 10 x 10 Tab.

59 MP0074 Dilitiazem Tablets I.P. 30 mg 10x10 Tab

21

60 MP0075 Dilitiazem Tablets I.P.60 mg 10x10 Tab

61 MP0076 Diphenhydramine Capsules I.P. 25mg 10x10 Cap

62 MP0082 Erythromycin Stearate tab I.P. 250 mg 10 x 10 Tab.

63 MP0083 Erythromycin Stearate tab I.P. 500 mg 10 x 10 Tab.

64 MP0084 Escitalopram Tablets I.P. 10 mg tab 10 x 10 Tab

65 MP0085 Ethinyl Estradiol and Norethindrone (Norethisterone)

Tablets USP 35 mcg +1mg 21 Tab

66 MP0086 Etiophylline (77 mg) + theophylline (23 mg) Tab 10 x 10 Tab.

67 MP0087 Fluconozole Tablets I.P. 150mg 10 x 10 Tab.

68 MP0088 Fludrocortisone Tablets I.P 100mcg 10 x 10 Tab

69 MP0092 Folic Acid Tablets I.P - 5 mg 10 x 10 Tab.

70 MP0093 Frusemide Tablets I.P. 40mg 10 x 10 Tab.

71 MP0094 Furazolidaone 100 mg Tab 10x 10 Tab

72 MP0095 Glibenclamide Tablets I.P. 2.5mg 10 x 10 Tab

73 MP0096 GlibenclamideTablets I.P. 5mg 10 x 10 Tab

74 MP0097 Gliclazide Tablets I.P. 80 mg 10 x 10 Tab

75 MP0101 Griseofulvin Tablets I.P. 125 mg 10 x 10 Tab

76 MP0102 Haloperidol Tablets I.P. 5mg 10 x 10 Tab

77 MP0103 Hydrochlorothiazide Tablets I.P. 25 mg 10 x 10 Tab.

78 MP0104 Hydroxymethyl Psoralin Tab. 10 mg 10 x 10 Tab

79 MP0105 Hyoscine Butylbromide Tablets I.P. 10mg, 10 x 10 Tab

80 MP0106 Ibuprofen Tablets I.P. 400mg 10 x 10 Tab

81 MP0107

Iron and folic acid enteric coated Tab. Dried Ferrous

Sulphate IP eq. to Ferrous Iron 100 mg & Folic Acid IP

0.5 mg(Colour coding should be done as per directions

of DCGI/MoHFW ARSH program)

10x10 Tab.

82 MP0108

Iron and folic acid enteric coated Tab. Dried Ferrous


100 mcg

10x10 Tab.

83 MP0115 Lactobacillus Tablet (Lactobacillus 60 million

spores/Tablet) 10 x 10 Tab.

84 MP0116 Levocetirizine Tablets I.P. 5mg 10 x 10 Tab

85 MP0119 Levonorgestrel Emergency contraceptive 0.75 mg Tab. 2 Tab

86 MP0120 Levo-Norgestryl+Ethinyl Estradiol IP

(0.25mg+0.05mg)Tab 21 Tab

87 MP0123 Mebendazole Tablets I.P.100mg 10 x 10 Tab

88 MP0125 Mesalamine (5-Aminosalicylic Acid) USP tab 400mg 10 x 10 Tab.

89 MP0126 Mesalamine (5-Aminosalicylic Acid) USP tab 800mg 10 x 10 Tab.

90 MP013 Atenolol Tab. - 50mg 14 x 10 Tab.

91 MP0131 Metoprolol Tablets I.P. 50mg 10 x 10 Tab

92 MP0132 Metronidazole Tab 200mg 10x 10tab

93 MP0133 Metronidazole Tablets I.P 400mg 10 x 10 Tab

94 MP0134 Mifepristone 200mg Tab 10 x 10 Tab

95 MP0136

Multivitamin Tablets NFI Formula Sugar coated- Vit A

2500 IU, Vit B1-2mg, Vit- B6-0.5mg, Vit-C-50mg,

Calcium Pantothenate-1mg, Vit-D3-200IU, Vit-B2 2 mg,

Niacinamide-25mg, Folic Acid-0.2mg

10 X 10

96 MP0137 Naproxen Tablets I.P.500mg 10 x 10 Tab

22

97 MP0142 Ofloxacin+Ornidazole (200mg+500mg) Tab 10 x 10 Tab

98 MP0146 Pantoprazole Tablets I.P 40mg 10 x 10 Tab

99 MP0147 Paracetamol Tablets I.P- 500mg 10 x 10 Tab

100 MP0148 Phenobarbitone Tablets I.P 60mg 10 x 10 Tab

101 MP0149 Phenobarbitone Tablets I.P. 30 mg 10 x 10 Tab

102 MP0150 Phenytoin Sodium Tablets I.P. - 100mg 10 x 10 Tab

103 MP0151 Piogliatazone Tablets I.P. - 15mg 10 x 10 Tab

104 MP0152 Piogliatazone Tablets I.P. - 7.5 mg 10 x 10 Tab

105 MP0153 Piroxicam Capsules IP 20 mg 10 x 10 Tab

106 MP0154 Prazosin Tablets I.P. - 5mg 10 x 10 Tab

107 MP0156 Primaquin Tab-7.5mg 10x10Tab

108 MP0157 Primaquine Tablets I.P.15mg 10x10 Tab

109 MP0158 Primaquine Tablets I.P.2.5 mg 10 x 10 Tab.

110 MP0159 Promethazine Tablets I.P. 25mg 10 x 10 Tab

111 MP0160 Propranolol Tablets I.P. 10 mg 10x10 Tab

112 MP0161 Propranolol Tablets I.P.40 mg 10 x 10 Tab

113 MP0163 Quinine Sulphate Tablets I.P. - 300mg 10x10 Tab

114 MP0164 Quinine Sulphate Tablets I.P. - 600mg 10x10 Tab

115 MP0165 Rabeprazole Tablets I.P 20mg 10 x 10 Tab

116 MP0166 Ramipril Tablets I.P. 2.5mg 10 x 10 Tab

117 MP0167 Ramipril Tablets I.P. 5mg 10 x 10 Tab

118 MP0171 Sodium Valproate Tablets I.P. 200 mg 10 x 10 Tab

119 MP0172 Spironolactone Tablets I.P. 25 mg 10 x 10 Tab.

120 MP0173 Sulfamethoxazole and Trimethoprim Tab. IP (800

mg+160mg) 10 x 10 Tab

121 MP0174 Sulphadoxine and Pyrimethamine Tablets

I.P.(Sulphadoxine 500mg -Pyrimethamine25mg tab ) 10x10 Tab

122 MP0175 Telmisartan Tablets I.P. 40mg 10 x 10 Tab

123 MP0176 Telmisartan Tablets I.P.20mg 10 x 10 Tab

124 MP0178 Thyroxine sodium Tablets I.P. 100mcg 10 x 10 Tab

125 MP0179 Thyroxine sodium Tablets I.P. 50 mcg 10 x 10 Tab

126 MP0180 Tinidazole Tablets I.P 500mg 10 x 10 Tab.

127 MP0181 Torsemide Tab USP 10mg 10 x 10 Tab.

128 MP0182 Torsemide Tab USP 20mg 10x10 Tab.

129 MP0184 Triamcinolone Tablets I.P.4mg 10 x 10 Tab

130 MP0185 Trihexyphenydyl Tablets 2mg. 10 x 10 Tab

131 MP0186 Verapamil Tablets I.P. - 40mg 10 x 10 Tab

132 MP0187 Vitamin A cap USP Soft Gelatin Capsule 2 Lakh IU 10x 10 Cap

133 MP0188 Vitamin A cap USP Soft Gelatin Capsule 1 Lakh IU 10 x 10 CAP

134 MP0189 Warfarin Sodium Tablets I.P 5 mg 10x10 Tab

135 MP0190

Zinc Sulphate Dispersible Tablets Strength: Each tablet

contains Zinc Sulphate IP eq. to Elemental Zinc 20mg

(Bitter taste to be masked)

10 x 10 Tab

136 MP033 Ciprofloxacin Tab - 250mg 10 x 10 Tab.

137 MP0416 Deferasirox dispersible Tab. - 100mg 30 Tab


23



141 MP0431 Rifampicin Cap 150 mg 10x10

142 MP0432 Atenolol Tab 50mg. 14x10

143 MP0435

Iron & folic acid entric coated Tab. Large Dried Ferrous


0.5 mg

10x10

144 MP0436 Norfloxacin Tab. - 400mg 10x10

145 MP0437 Sulfamethoxazole 100 mg and Trimethoprim 20mg Tab. 10x10

146 MP0438 Sulfamethoxazole 400mg and Trimethoprim 80mg Tab. 10x10

147 MP0439 Vitamin. B complex tab. NFI (PROPHYLACTIC) 10x10

148 MP0450 Methyl Prednisolone Tab - 16 mg 10x10

149 MP0464 Gemcitabine -200mg Inj. Vial

150 MP0465 Gemcitabine -1000mg Inj. Vial

151 MP0487 Temozolomide -20mg cap 10x10



154 MP0490 Procarbazine- 50 mg cap 10x10

155 MP0491 Lomustine 40 mg cap 4 Capsule

156 MP0492 Cyclophosphamide -50mg Tab 10x10

157 MP0493 Tamoxifen -10mg Tab 10x10

158 MP0494 Tamoxifen -20mg Tab 10x10

159 MP0495 Methotrexate -2.5mg Tab 10x10

160 MP0496 Methotrexate -5mg Tab 10x10

161 MP0497 Methotrexate -10mg Tab 10x10

162 MP058

Iron and folic acid entric coated TabStrength:Ferrous

Sulphate dessicated IP 333.335mg equivalent to 100mg

of elemental iron+Folic acid IP0.5mg.

11 x 10 Tab.

163 MP109 Sulfamethoxazole and Trimethoprim Tab.

(100mg+20mg) 10 x 10 Tab.

164 MP110 Sulfamethoxazole and Trimethoprim Tab. (400mg +80

mg) 10 x 10 Tab.

165 MP122 Vitamin. B complex tab. NFI (PROPHYLACTIC) 10 x 10 Tab.

166 MP149b Diclofenac Sodium Tab - 50 mg 10 x 10 Tab.

167 MP308 Calcium Citrate - 1000mg (Elemental Ca equivalent to

250 mg and Vitamin D3 400 IU 10 x 10 Tab.

168 MP315 Methyl Prednisolone Tab. - 4mg 10 x 10 Tab.

169 MP316 Methyl Prednisolone Tab. - 16mg 10 x 10 Tab.

170 MP0191 Acylovir Intervenous Infusion I.P. - 500mg/vial Vial

171 MP0192 Adenosine Inj 6mg/2ml 2ml vial

172 MP0194 Adrenochrome Monosemicarbazone Inj - 0.75mg /ml. 2 ml amp

173 MP0197 Amikacin Injection I.P. - 100 mg/2ml 2 ml Vial



176 MP0200 Aminophylline Injection I.P. - 25 mg/ml 10 ml Amp

177 MP0202 Amoxycillin and Potassium Clavulanate Injection I.P.

(1gm+0.2gm)/10ml. Vial

24

178 MP0204 Ampicillin Injection I.P.- 250 mg/vial Vial

179 MP0209 Alpha-Beta Arteether inj 150mg/2ml 3 Vials of 2 ml

180 MP0210 Artesunate Injection - 60 mg /vial Vial

181 MP0213 Azithromycin Oral Suspension I.P.- 200mg/5ml 15 ml Bottle

182 MP0216 Benzathine penicillin powder for Inj IP 12 lakh IU/vial 5 ml Vial

183 MP0217 Benzathine penicillin powder for Inj IP 6 lakh IU/vial 5 ml Vial

184 MP0219 Benzyl penicillin powder for Inj IP 10 lakh IU/vial Vial

185 MP0220 Betamethasone Sodium Phosphate Inj.I.P. 4mg/ml 1ml Amp

186 MP0221 Biperiden Lactate Inj USP 5mg/ml 1ml Amp

187 MP0222 Biphasic Isophane Insulin Injection IP 30/70 (30%

Soluble Insulin & 70% Isophane Insulin) 40 IU/ml 10 ml Vial

188 MP0224 Budesonide Nebulising suspension containing

Budesonide IP 0.25mg/per ml 2 ml Amp

189 MP0227 Bupivacaine hydrochloride inj 0.5% heavy 4ml amp

190 MP0229 Calcium Chloride Injection I.P. 10 ml Amp

191 MP0230 Calcium gluconate Injection I.P. - 10%w/v 10 ml Amp

192 MP0231 Carboprost Tromethamine Injection I.P.(15-methyl

PGF2α)inj 250mcg/1ml Amp

193 MP0232 Cefazolin Injection I.P.1gm Vial

194 MP0233 Cefotaxime sodium Injection I.P.- 1 gm 1 gm Vial

195 MP0234 Cefotaxime sodium Injection I.P.- 250 mg 250 mg Vial

196 MP0235 Ceftazidime Injection I.P. 0.5gm/vial Vial

197 MP0236 Ceftazidime Injection I.P. 250 mg/vial Vial

198 MP0237 Ceftazidime Injection I.P.1gm/vial Vial

199 MP0238 Ceftriaxone inj.I.P. - 1gm/vial 1 gm Vial

200 MP0239 Ceftriaxone inj.I.P.- 250mg/vial 250 mg Vial

201 MP0241 Cetrimide IP+Choline Salicylate BP+Lignocaine Hcl IP gel

(0.01%+8%+2% w/v) 15ml bottle

202 MP0246 Chlorpheniramine Injection I.P. 10mg/ml 10 ml Vial

203 MP0247 Chlorpromazine Hydrochloride Injection I.P. 25mg/ml 2ml Amp.

204 MP0248 Chorionic Gonadotropin Injection I.P. 5000 IU 1 ml Amp

205 MP0250 Ciprofloxacin Injection I.P. 100 mg/50ml 100 ml FFS/ BFS

Bottle

206 MP0252 Clindamycin Injection 150 mg/ml Vial

207 MP0253 Clonidine Injection I.P. 150 mcg/ml Vial

208 MP0255 Cloxacillin Sodium Injection I.P. - 500mg Vial

209 MP0259 Desferrioxamine Inj. IP - 0.5g/vial Vial

210 MP0260 Dexamethasone sodium phosphate Injection I.P.

4mg/ml 2 ml Vial

211 MP0261 Dextran 70 Injection I.P.(Solution) 500ml Bottle

212 MP0262 Dextrose Injection I.P. 25%

500 ml FFS/ BFS

Bottle (Single

Stage Technology

213 MP0263 Dextrose Injection I.P.50%

500 ml FFS/ BFS

Bottle (Single

Stage Technology

25

214 MP0265 Diclofenac sodium Injection I.P. - 25 mg/ml 3 ml Amp

215 MP0266 Dicyclomine Injection I.P. - 10 mg/ml 2 ml Vial

216 MP0267 Dicyclomine Oral Solution IP 10mg/5 ml) 30 ml Bottle

217 MP0268 Digoxin Injection I.P. 250mcg/ml 2 ml Amp

218 MP0269 Dilitizem Inj IM 5mg/ml 5ml vial

219 MP0270 Dimercaprol Injection I.P. in oil 50mg/ml 2 ml Amp

220 MP0273 Dobutamine inj.B.P. - 50mg/ml 5 ml Amp

221 MP0274 Domperidone Suspension contains Domperidone IP

5mg/5ml 30 ml Bottle

222 MP0275 Dopamine Inj.B.P. - 40 mg/ml 5 ml Amp

223 MP0276 Drotaverine inj. - 40mg/2ml vial

224 MP0279 Ethacridine Lactate Inj Ethacridine Lactate-0.1 %, 50

ml vials (3 vials -1 case) 3 vials -1 case

225 MP0280 Etiophylline (169.4mg/ml)and theophylline (50.6mg/ml)

Inj. - 220 mg/2ml 2 ml Amp

226 MP0282 Fentanyl Injection I.P. 50 mcg/ml 2 ml Amp

227 MP0285 Fluphenazine Decanoate Injection I.P. 2.5 mg/ml 1 ml Amp

228 MP0287 Frusemide Injection I.P. 10 mg/ml 2 ml Amp

229 MP0292 Glycopyrrolate Inj 0.2mg/ml 1 ml Amp

230 MP0293 Haloperidol Injection I.P. 5mg/ml 1 ml Amp

231 MP0295 Heparin Injection I.P. 1000 IU /ml 5 ml Vial

232 MP0296 Heparin Injection I.P. 5000 IU/ml 5 ml Vial

233 MP0297 Human Albumin Solution I.P. 20%w/v 50 ml Vial

234 MP0299 Hyaluronidase Injection I.P. 1500 IU 1 ml Amp

235 MP0300 Hydrocortisone sodium succinate Injection I.P. 100

mg/vial 100 mg Vial

236 MP0302 Hydroxyethylstarch 6% Solution

IV infusion

500 ml Bottle

FFS/BFS

237 MP0303 Hydroxyprogesterone Caproate Injection I.P. 250mg/ml 1 ml Amp

238 MP0304 Hyoscine Butylbromide Injection I.P. 20mg/ml 1 ml Vial

239 MP0307 Ipratropium Bromide powder for inhalation I.P. 250

mcg per ml 15 ml Vial

240 MP0308

Iron Sucrose Injection USP (For IV Use) Each ml contain:

Ferric hydroxide in complex with Sucrose equivalent to

elemental Iron 20 mg

5 ml Amp (amber

coloured

ampoule)

241 MP0310 Ketamine hydrochloride Injection I.P. 50 mg/ml 10 ml Amp

242 MP0311 Labetalol Hydrochloride inj. 20mg/4ml 4ml Amp

243 MP0313 Lignocaine Hydrochloride Topical solution USP 4 % 30ml Vial

244 MP0315 Lindane Lotion USP (Gamma benzene hexachloride

Lotion 1% w/v) 50 ml Bottle

245 MP0317 LMWH low molecular weight Heparin inj. - 4000 IU/ml Vial

246 MP0318 LMWH low molecular weight Heparin inj. - 6000 IU/ml Vial

247 MP0319 Magnesium suplhate injection I.P. 50 % w/v 1 ml Amp

248 MP0320 Mannitol Injection I.P. 10% 100 ml Bottle

249 MP0321 Mannitol Injection I.P. 20% 100 ml Bottle

250 MP0323 Mephentermine Injection I.P. 15 mg/ml 10ml vial

251 MP0324 Methyl Prednisolone sodium succinate inj. USP -

500mg Vial

26

252 MP0325 Methyl Prednisolone sodium succinate inj. USP - 125mg Vial

253 MP0326 Methylergometrine injection I.P. - 0.2 mg /ml 1 ml Amp

254 MP0327 Methylthioninium Chloride injection B.P. (Methlene

Blue)10mg/ml 10ml Amp

255 MP0328 Metoclopramide Injection I.P. 5mg/ml 2 ml Amp

256 MP0329 Metoprolol inj. B.P.- 1 mg/ml Vial

257 MP0331 Midazolam Inj.USP - 1 mg/ml 5 ml Amp.

258 MP0332 Morphine sulphate Injection I.P - 10 mg/ml 1 ml Amp

259 MP0334 Multiple Electrolyte "E"inj IP

500 ml FFS/ BFS

Bottle (Single

Stage Technology

260 MP0335 Multiple Electrolyte G Inj. IP

500 ml FFS/ BFS

Bottle (Single

Stage Technology

261 MP0336 Multiple electrolytes & dextrose Injection Type I IP

(Electrolyte P Injection)

500 ml FFS/ BFS

Bottle (Single

Stage Technology

262 MP0337 Multiple electrolytes & dextrose Injection Type III IP

(Electrolyte "M" Injection)

500 ml FFS/ BFS

Bottle (Single

Stage Technology

263 MP0339 N- Acetyl Cysteine Injection 200mg/ml 5 ml vial

264 MP0340 Neostigmine Injection I.P. 2.5mg/5ml 1 ml Amp

265 MP0341 Nitroglycerine inj. USP - 25 mg/5ml 5 ml Amp

266 MP0344 Ondansetron Injection I.P. 2 mg/ ml 2 ml Amp.

267 MP0346 Oxytocin Injection I.P. 5 IU/ml 1 ml Amp (Blister

Pack only)

268 MP0350 Pheniramine Inj. IP - 22.75 mg/ml 2 ml Amp

269 MP0352 Phenobarbitone Injection I.P. 200mg/ml 1 ml Amp

270 MP0354 Phenytoin sodium Injection. BP - 50 mg/ml 2 ml Amp

271 MP0358 Piperacillin + Tazobactam - 4gm +0.5gm Inj. Vial

272 MP0359 Piroxicam inj 40 mg/2ml Amp

273 MP0360 Potassium chloride (0.15%w/v) inj. IP 10 ml Amp

274 MP0361 Potassium chloride Oral solution 100mg/ml 15 ml Bottle

275 MP0364 Pralidoxime Chloride Injection I.P. (PAM)- 1g 20 ml Amp

276 MP0365 Progesterone Injectable Suspensin I.P. (Micronised

Progestron inj. )- 100mg/ml 1 ml Amp

277 MP0367 Propofol Injection I.P. 1%w/v 10mg/ml 20 ml Vial

278 MP0368 Protamine Sulphate Injection I.P.10mg/ml 5ml Amp

279 MP0369 Quinine dihydrochloride Inj. - 300mg/ml . 2 ml Amp

280 MP0371 Ranitidine Injection I.P. 50mg/2ml 2 ml Amp

281 MP0372 Salbutamol Nebuliser Solution BP Salbutamol sulphate

eq. to Salbutamol 1 mg per ml in each 2.5 ml ampoule Amp

282 MP0374 Sodium bicarbonate Injection I.P. 7.5% w/v 10 ml Amp

27

283 MP0375 Sodium Chloride N/2 Injection I.P. 1.6% w/v

500 ml FFS/ BFS

Bottle (Single

Stage Technology

284 MP0376 Streptokinase Injection I.P. 1,500,000 IU Vial

285 MP0380 Surfactant Suspension (For intratrcaheal) Natural

surfactant Inj 25 mg/ml 4 ml/5 ml amp.

286 MP0386 Thiopentone Sodium Injection I.P. 0.5 gm powder/vial 20 ml Vial

287 MP0388 Torsemide Inj USP 10 mg/ml 2 ml Amp

288 MP0389 Tramadol Inj. - 100mg/ml 2 ml Amp

289 MP0391 Tranexamic acid injection B.P. 100mg/ml 5 ml Amp

290 MP0393 Valethamate Bromide inj 8mg/ml 1 ml Amp

291 MP0394 Vecuronium Bromide (Lyophilized) Inj 4mg Each Vial/Amp

292 MP0396 Water for injection Inj.I.P. 10 ml FFS/ BFS

Bottle

293 MP0398 Beclomethasone Inhalation I.P. 200 mcg per dose 200 MDI Inhaler

294 MP0430 Streptomycin injection 0.75 gm Vial

295 MP0430 Streptomycin injection 0.75 gm Vial

296 MP0441 Naloxone Inj. - 0.4 mg/ml Vial

297 MP0448 Calcium Citrate - 1000mg (Elemental Ca equivalent to

250 mg and Vitamin D3 400 IU) 10x10

298 MP0451 Doxorubicin -10mg Inj. 5 ml Vial

299 MP0452 Doxorubicin -50mg Inj. 25 ml Vial

300 MP0453 Cisplatin -10mg Inj. 10 ml Vial

301 MP0454 Cisplatin -50mg Inj. 50 ml Vial

302 MP0455 Carboplatin -150mg Inj. 15 ml Vial

303 MP0456 Carboplatin -450mg Inj. 45 ml Vial

304 MP0457 Paclitaxel -30mg Inj. Vial

305 MP0458 Paclitaxel -100mg Inj. 16.7 ml Vial

306 MP0459 Paclitaxel -260mg Inj. 43.4 ml Vial

307 MP0460 Paclitaxel -300mg Inj. Vial

308 MP0461 Docetaxel -20mg Inj. Vial



311 MP0466 Oxaliplatin -50mg Inj. 25 ml Vial

312 MP0467 Oxaliplatin -100mg Inj. Vial

313 MP0468 Trastuzumab -440mg Inj. Vial

314 MP0469 Rituximab -100mg Inj. Vial

315 MP0470 Rituximab -500mg Inj. Vial

316 MP0471 Bortezomib -2mg Inj. Amp

317 MP0472 Bortezomib -3.5mg Inj. Vial

318 MP0473 Bevacizumab -100 IU Inj. 4 ml Vial

319 MP0474 5-fluorouracil (5-FU) -250mg Inj. 5 ml Amp

320 MP0475 5-Fluorouracil (5-FU) -500mg Inj. Vial

321 MP0476 Vincristine -1mg Inj. 1 ml Vial

28

322 MP0477

Cyclophosphamide -200mg Inj. 10 ml glass Vial

323 MP0478 Cyclophosphamide -500mg Inj. Vial

324 MP0479 Cyclophosphamide -1000mg Inj. Vial

325 MP0480 Epirubicin -10mg Inj. Vial

326 MP0481 Epirubicin -50mg Inj. Vial

327 MP0482 Methotrexate -15mg Inj. Vial

328 MP0483 Methotrexate -50mg Inj. 2 ml

329 MP0484 Methotrexate -500mg Inj. Vial

330 MP0485 Vinblastine -10mg Inj. 10 ml Vial

331 MP0486 Etoposide -100mg Inj. 5 ml glass Vial

332 MP178 Naloxone Inj. - 0.4 mg/ml 1 ml Amp

333 MP242 Inj. Dextrose 5% - 500ml 500ml FFS/BFS

Bottle

334 MP243 Inj. Dextrose 10% - 500ml 500ml FFS/BFS

Bottle

335 MP246 Inj. Sodium Chloride 0.9% - 500ml 500ml FFS/BFS

Bottle

336 MP247 Compound Sodium Lactate IP - 500ml 500ml FFS/BFS

Bottle

337 MP248 Sodium Chloride and Dextrose Inj. IP - 500ml 500ml FFS/BFS

Bottle

338 MP0195 Albendazole Suspension - 200mg/5ml 10ml Bottle

339 MP0196

Alkaline Citrate with Potassium oral solution each 10

ml contains sodium citrate IP 1 gram Potassium citrate

IP 0.65 gram citric acid IP1 gram 100 ml bottle

100 ml Bottle

340 MP0211 Atropine Eye drops BP - 1% w/v 5 ml Vial

341 MP0213 Azithromycin Oral Suspension I.P.- 200mg/5ml 15 ml Bottle

342 MP0214 Barium Sulphate Suspension I.P.10%w/v 500 ml

343 MP0215 Benedicts Solution (Qualitative) - 500 ml 500 ml Bottle

344 MP0218 Benzyl Benzoate Application I.P. - 25%w/w 100ml Bottle

345 MP0223 Bromhexine hydrochloride Syrup containing

Bromhexine Hydrochloride IP 4 mg/5 ml 50 ml Bottle

346 MP0228 Calamine Lotion I.P. 100ml Bottle

347 MP0240 Cephalexine Oral Suspension IP 125mg/5ml 30 ml Bottle

348 MP0242 Chloramphenicol Eye drops I.P.- 0.5%w/v 5 ml Vial

349 MP0243 Chlorhexidine Gluconate Solution 4 % I.P.(Antiseptic) 500ml Bottle

350 MP0245 Chloroquine Phosphate Suspension I.P.Equivalent to

Chloroquine 50 mg/5ml 60 ml Bottle

351 MP0249 Ciprofloxacin Eye drops I.P.0.3%w/v 5 ml Vial

352 MP0251 Ciprofloxacin IP 0.3% w/v + Dexamethasone IP 0.1%

w/v Eye drop 10 ml vial

353 MP0254 Clotrimazole ear drop 1% w/v 5 ml Vial

354 MP0257

Cough Syrup (Each 5ml Contains Diphenhydramine HCL

14.08 mg Ammonium Chloride 138mg, Sodium Citrate

57.03 mg, Menthol 2.5mg)

50 ml Bottle

355 MP0278 Ergocalciferol Oral Solution USP 250mcg/ml

(10000IU/ml) Bottle

29

356 MP0281 Etiophylline (46.5 mg/5ml)and Theophylline (14

mg/5ml) Paediatric Syrup. 100 ml Bottle

357 MP0284 Fluoroscein Sodium Eye drops I.P. 1% w/v 5 ml Vial

358 MP0286 Formaldehyde IP (Formalin) 450 ml Bottle

359 MP0288 Furazolidone Oral Suspension I.P. 25mg/5ml 60 ml Bottle

360 MP0289 Gentamicin +betamethasone Eye drops USP (0.3%) 5ml

FFS/BFS vial 5 ml Vial

361 MP0294 Halothane B.P. 250 ml Bottle

362 MP0301 Hydrogen Peroxide Sol I.P.6%v 400ml Bottle

363 MP0305

IFA Syrup Ferrous iron (derived from Ferrous Sulphate)

100mg and Folic Acid IP 0.5 mg per 5ml (Each bottle

provided with a pipette dropper to dispense 1 ml.The

pipette part should be fabricated from polypropylene &

pump part from PVC.)

100 ml Bottle

364 MP0333 Moxifloxacine Eye drop 0.5%w/v 5 ml Vial

365 MP0338

Multivitamin drops (Approx 22 drops) Each ml contains

Vit A 3000 IU Vit B1 1 mg Riboflavin Phosphate sodium

2 mg,Panthenol 2.5 mg Niacinamide 10 mg Pyridoxin 1

mg Cynacobalime 1 mcg Lycine 10 mg 15 ml

15 ml

366 MP0342 Ofloxacin Eye drop 0.3% W/V of Ofloxacin Ph.Eur. 5 ml Vial

367 MP0343 Olopotadine antiallergic Eye drop 0.1 % w/v 5 ml Vial

368 MP0345 Ondansetron Syrup I.P.2mg/5ml 30 ml Bottle

369 MP0347 Paracetamol Syrup I.P.- 125 mg/5ml 60 ml Bottle

370 MP0349 Permethrin Lotion 5% w/v 60 ml Bottle

371 MP0351 Phenobarbitone Syrup 20mg/5ml 60ml Bottle

372 MP0353 Phenytoin Oral Suspension I.P. - 25 mg/ml, 100ml Bottle

373 MP0355 Pilocarpin PFS Eye Drops 1% vial

374 MP0356 Pilocarpine Hydrochloride Eye drops BP 2% 5 ml Vial

375 MP0357 Pilocarpine Hydrochloride Eye drops BP 4% 5 ml Vial

376 MP0358 Piperacillin + Tazobactam - 4gm +0.5gm Inj. Vial

377 MP0360 Potassium chloride inj. - 150 mg/ 10ml 10 ml Amp

378 MP0362 Povidone iodine Solution. I.P. surgical scrub - 7.5%w/v 500 ml Bottle

379 MP0363 Povidone iodine Solution I.P. 5%w/v 100 ml Bottle

380 MP0366 Promethazine Syrup I.P. 5 mg/5ml 60 ml Bottle

381 MP0368 Protamine Sulphate Injection I.P.10mg/ml 5ml Amp

382 MP0371 Ranitidine Inj. - 50mg/2ml 2 ml Amp

383 MP0372 Salbutamol Nebuliser Solution BP-Sabutamol Sulphate

eq. to Salbutamol 1mg per ml 2.5 ml Amp

384 MP0374 Sodium bicarbonate Inj. - 7.5% w/v 10 ml Amp

385 MP0377 Succinyl Choline Inj. - 50mg/ml 1 ml Amp

386 MP0378 Sulfacetamide Eye drops I.P.- 20%w/v 10 ml Vial

387 MP0379 Sulfamethoxazole andTrimethoprim Suspension IP (200

mg + 40 mg in 5 ml) 50 ml Bottle

388 MP0382 Tannic Acid (with glycerin) Gum Paints 15% w/v 10ml vial Dental

preparation

389 MP0385 Tetanus Immunoglobulin USP - 250 IU/vial Vial

390 MP0387 Timolol Maleate Eye drop I.P. 0.5 %w/v 5 ml Vial

30

391 MP0388 Torsemide Inj USP 10 mg/ml 2 ml Amp

392 MP0390 Tramadol Inj. - 50mg/ml. 2 ml Amp

393 MP0391 Tranexamic Acid Injection BP 100mg/ml 5 ml Amp

394 MP0392 Tropicamide Eye drops I.P. - 1%w/v 5 ml Vial

395 MP0395

Vitamin. A Syrup 100000 I.U./ml I.P.(Oil base Vitamin A

concentrate) with food grade plastic spoon with 1 ml

and 2ml demarcation

100 ml Bottle

with spoon

396 MP0397 Xylometazoline Nasal drops I.P. 0.1%w/v 10 ml Vial

397 MP0399 Benzoyl Peroxide Gel BP 2.5% w/w, 20 gm Tube

398 MP0400 Betamethasone Valerate Ointment IP. - 0.1%w/w 15gm Tube

399 MP0401 Black Disinfectant Fluid (Phenyl) As per Schedule "O"

Grade-III 5 Ltr. Can

400 MP0402 Cetrimide + Chlorhexidine (conc.) (15%v/v+7.5%v/v)

Concentrate Solutiion 1 Liter Jar

401 MP0403 Cholecalciferol Concentrate (Powder Form) Ph.Eur.

60000IU/gm 1gram Sachet

402 MP0404 Clotrimazole cream I.P.- 2%w/w 15 gm Cream

403 MP0406 Gluteraldehyde Solution B.P. - 2% w/v with Stabiliser 5 Ltr. Cans

404 MP0407 Lignocaine Hydrochloride Gel I.P.2% w/v 30 gm Tube

405 MP0408 Lysol IP (Cresol with Soap Solution I.P.) 50% Cresol+50%

Soap 5 Ltr. Cans

406 MP0409 Miconazole Cream I.P. 2% w/w 15 gm Tube

407 MP0410 ORS Packet WHO Formula 20.5gm Pouch

408 MP0411 Salbutamol inhalation I.P.( Inhaler) 100mcg/dose

200 Metered

dose container(

Inhaler)

409 MP0412 Salicylic acid ointment BP 2%w/w 80g Tube

410 MP0413 Silver Sulphadiazine cream USP 1% w/w 25 gm Tube

411 MP0415 Framycetin sulphate 1%w/w cream 30 gm

412 MP0422 Metronidazole Benzoate oral Suspension 100mg of

base/5 ml 60 ml Bottle

413 MP0424 Paracetamol Drop 100mg/ml 15 ml Bottle with

Dropper

414 MP0425 Cefalexin Oral Drop 100mg/ml 10 ml Bottle with

Dropper

415 MP0426 Domperidone Drops 10mg/ml 5 ml Bottle with

Dropper

416 MP0427 Vitamin E Drops 50mg/ml 15 ml Bottle with

Dropper

417 MP0498 Sodium Chloride 0.9 % Injection IP 100 ml Bottle

418 MP0499 Lactulose solution 3.35gm/5 ml 100 ml Bottle

419 MP0206 Anti D Immunoglobulin Human for I.V./I.M. Use

I.P.(monoclonal) Inj. 150 mcg 1 ml Vial

420 MP0207 Anti D Immunoglobulin Human for I.V/I.M. Use I.P.

(Polyclonal) 300mcg/Vial

Pre-filled

Syringe/vial

421 MP0208 Anti Scorpion Venom Inj. 10 ml vial Vial

422 MP0271 Diptheria Antitoxine inj IP (10 ml AMP) 20000IU Vial

423 MP0272 Diptheria Antitoxine inj IP10000IU, (10 ml AMP) Vial

31

424 MP0277

Rabies Antiserum IP (Equine) 300 units per ml

[contains equine anti-rabies immunoglobulin

fragments](I.M./SC use)

5 ml Vial

425 MP0298 Human Antirabies Immunoglobulin Inj 300IU 2ml vial

426 MP0306 Insulin Injection IP (Human) - 40 IU/ml 10 ml Vial

427 MP0370 Rabies vaccine IP Human (cell culture) 2.5 IU/dose

(Intra Muscular use)

Single dose vial

with 0.5/1.0 ml

diluent and

syringe with

needle

428 MP0373 Snake venom Polyvalent Anti Serum IP liquid form

10ml polyvalent 10 ml vial

429 MP0384 Tetanous Vaccine Adsorbed IP (Tetanus toxiod Inj.) 5 ml Vial

430 MP0385 Tetanus Immunoglobulin USP - 250 IU/vial Vial

431 MP0420 Anti Hemophilic Factor IX complex (coagulation factor

II,VII,IX,X) Concentrate 600 IU Vial with solvent

432 MP0421 Anti Hemophilic Factor VIII Inj. 250 IU (monoclonal

Purified) Vial with diluent

433 MP0428 Recombinant factor VII A 1 mg Vial

434 MP0429 Recombinant factor VII A 2 mg Vial

435 MP194 Rabies vaccine IP Human (Cell Culture) 2.5 IU

Intradermal Vial

32

Annexure-VII Ref.Clause No: 3. D. m)

Format of Price Bid (online)

Sr. No.

Item Code Name of Item Charges for analysis of single sample (Rs.) (inclusive of all taxes but without service

tax)

Amount of Service Tax (if

applicable)

1 2 3 .. .. .. n

33

Annexure-VIII

CHECK LIST

COVER – A (Technical Bid)

1. Checklist – Annexure VIII Page No. 1 Yes No

2. EMD shall be kept in an envelope (Ref. Clause 3.D.a)

Page No. Yes No

3. Documentary evidence for the constitution of the Company / firm (Ref. Clause 3.D.b)

4. List of present Directors in the board (Ref. Clause 3.D.c)

5. Copy of Certificate of Accreditation issued by NABL duly certified by a Chartered Accountant (Ref. Clause 3.D.d.)

Page No. Yes No

6. Self attested and notarized copy of Analytical License under Rule 150(B) duly attested by a Chartered accountant (Ref. Clause 3.D.e)

7. Power of attorney / resolution of Board authorizing an officer of tenderer to sign the bid (Ref. Clause 3.D.f)

8. Authorization letter nominating responsible person of tenderer to transact the business with the tender inviting authority (Ref. Clause 3.D.g)

9. Quality manual, quality policy and master list of SOPs along with name of QA Manager indicating his qualification

34

and experience (Ref. Clause 3.D.h)

10. An Undertaking that the Laboratory will retain residual sample for six months after submission of report… (Ref. Clause 3.D.i)

11. Annexure – I

Performance Statement of last 5 financial years (Ref. Clause 2.c)

Page No. Yes No

12. Annexure – II

Self attested and notorised copy of Certificate of Registration of service tax (Ref. Clause 3.d.j)

Page No. Yes No

13. Self attested and notorised of the following documents:

14. Annexure – III (A)

List of Qualified personal employed in the laboratory

Page No. Yes No

15. Annexure – III (B)

List of Sophisticated instruments available in the Laboratory

Page No. Yes No

16. Annexure – III (C)

Micro biological Facilities available in the Laboratory

Page No. Yes No

17. Annexure – IV

Declaration form duly signed & notorised.

Page No. Yes No

18. Annexure - V

Details of Laboratory.

Page No. Yes No

35

19. Non Conviction Certificate issued by the competent authority for the last three years (Ref. Clause 3.D.n)

Page No. Yes No

20. Annual Turn-over statement for the last three years certified by the auditors (Ref. Clause 3.D.o)

Page No. Yes No

21. Balance Sheet & Profit – Loss Account for the last three years (Ref. Clause 3.D.o)

Page No. Yes No

22. Documentary evidence, if any for having testing of products for exports. (Ref. Clause 3.D.p)

Page No. Yes No

23. The list of Drugs (along with Item Code) quoted for analysis (Ref. Clause 3.d.r)

Page No. Yes No

24. The tender document signed by the tenderer in all pages with official seal (P.No:1 to 12)

Page No. Yes No

Cover C: Price Bid Yes No

25. Price Bid submitted online

Yes No

36

Annexure –IX

Ref. Clause No. 3.K.b)

AGREEMENT

THIS AGREEMENT made the ........... day of ......................... , 2014 between ___________________ (hereinafter "the Purchaser") of the one part and ____________________ (hereinafter called "the Service Provider") of the other part : WHEREAS the Purchaser is desirous that certain services viz;. Laboratory Analysis of Drugs and Medical Supplies of the items as per the tender Reference No. ___/GOMP/LAB/2014, Dt._______ and has accepted a bid by the Service Provider for the Laboratory Analysis. NOW THIS AGREEMENT WITNESSETH AS FOLLOWS:

1. In this Agreement words and expressions shall have the same meanings as are respectively assigned to them in the Conditions of Contract referred to, and they shall be deemed to form and be read and construed as part of this agreement.

2. The following documents shall be deemed to form and be read and construed as part of this Agreement, viz.:

a) The Letter of Acceptance issued by the purchaser.

b) The Terms and Conditions of Tender

c) The Service Provider’s bid including enclosures, annexures, etc.

d) The Terms and Conditions of the Contract

e) The Schedule of Requirement

f) The Technical Specification

g) Any other document listed in the Service Provider’s bid and replies to

queries, clarifications issued by the purchaser, such confirmations given by

the Service Provider which are acceptable to the purchaser and the entire

Addendum issued as forming part of the contract.

3. In consideration of the payments to be made by the Purchaser to the Service Provider as hereinafter mentioned, the Service Provider hereby covenants with the Purchaser to provide, the services in conformity in all respects with the provisions of the Contract.

4. The purchaser hereby covenants to pay the Service Provider in consideration of the provision of the services, the Contract Price or such other sum as may become payable under the provisions of the Contract at the times and in the manner prescribed by the Contract.

37

Brief particulars of the services which shall be provided by the Service Provider are as under.

S. No.

Item Code (to

be analyzed)

Name of the item (to be analyzed)

Brief Descriptio

n of Services

Price of analysis of single sample

(Rs.)

Service tax in %

Total value

inclusive of Service

tax

Performance Requirements: The Service Provider should furnish the test reports within:

(i) 10 days of receipt of the sample in case of Tablets, Capsules, Pessaries, Ointments, Powder and Liquid Oral Preparations.

(ii) 25 days of receipt of the sample in the case of I.V. Fluids, Injections, eye/ear drops Disinfectants and those items requiring sterility testing.

IN WITNESS where of the parties here to have caused this Agreement to be executed in accordance with their respective laws the day and year first above written. Signed, Sealed and Delivered by the Said Directorate of health Services, Department of Public Health and Family Welfare, Govt. of Madhya Pradesh (For the Purchaser) in the presence of .......................................... Signature Name Address Witness 1. 2. Signed, Sealed and Delivered by the Said M/s ___________________ (For the Service Provider) in the presence of .......................................... Signature Name Address

Witness 1. 2.

TENDER DOCUMENT (Not Transferable)

Documents

Transcript of TENDER DOCUMENT (Not Transferable)